70
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Nitroglycerin enhances the propagation of cortical spreading depression: comparative studies with sumatriptan and novel kynurenic acid analogues

, , , &
Pages 27-34 | Published online: 20 Dec 2016

References

  • LiptonRBBigalMEToward an epidemiology of refractory migraine: current knowledge and issues for future researchHeadache2008486 791 79818479422
  • Jansen-OlesenITfelt-HansenPOlesenJAnimal migraine models for drug development: status and future perspectivesCNS Drugs20132712 1049 106824234657
  • AyataCCortical spreading depression triggers migraine attack: proHeadache2010504 725 73020456160
  • SomjenGGAristides Leão’s discovery of cortical spreading depressionJ Neurophysiol2005941 2 415985690
  • TotteneAUrbaniAPietrobonDRole of different voltage-gated Ca2+ channels in cortical spreading depression: specific requirement of P/Q-type Ca2+ channelsChannels (Austin)201152 110 11421150292
  • PeetersMGunthorpeMJStrijbosPJGoldsmithPUptonNJamesMFEffects of pan- and subtype-selective N-methyl-D-aspartate receptor antagonists on cortical spreading depression in the rat: therapeutic potential for migraineJ Pharmacol Exp Ther20073212 564 57217267580
  • RichterFEbersbergerASchaibleHGBlockade of voltage-gated calcium channels in rat inhibits repetitive cortical spreading depressionNeurosci Lett20023342 123 12612435487
  • AyataCSpreading depression: from serendipity to targeted therapy in migraine prophylaxisCephalalgia20092910 1095 111419735536
  • HaghirHKovacSSpeckmannEJZillesKGorjiAPatterns of neurotransmitter receptor distributions following cortical spreading depressionNeuroscience20091634 1340 135219665048
  • ColonnaDMMengWDealDDBusijaDWNitric oxide promotes arteriolar dilation during cortical spreading depression in rabbitsStroke19942512 2463 24707526490
  • PiperRDLambertGADuckworthJWCortical blood flow changes during spreading depression in catsAm J Physiol19912611 Pt 2 H96 H1021858935
  • OlesenJThomsenLLIversenHNitric oxide is a key molecule in migraine and other vascular headachesTrends Pharmacol Sci1994155 149 1537538702
  • TassorelliCJosephSASystemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the ratBrain Res19956821–2 167 1817552308
  • GrecoRMeazzaCMangioneASTemporal profile of vascular changes induced by systemic nitroglycerin in the meningeal and cortical districtsCephalalgia2011312 190 19820693231
  • StreckerTDuxMMesslingerKNitric oxide releases calcitonin-gene-related peptide from rat dura mater encephali promoting increases in meningeal blood flowJ Vasc Res2002396 489 49612566974
  • TassorelliCJosephSANADPH-diaphorase activity and Fos expression in brain nuclei following nitroglycerin administrationBrain Res19956951 37 448574645
  • SchwarczRBrunoJPMuchowskiPJWuHQKynurenines in the mammalian brain: when physiology meets pathologyNat Rev Neurosci2012137 465 47722678511
  • VecseiLSzalardyLFulopFToldiJKynurenines in the CNS: recent advances and new questionsNat Rev Drug Discov2013121 64 8223237916
  • Knyihár-CsillikEChadaideZOkunoEKynurenine aminotransferase in the supratentorial dura mater of the rat: effect of stimulation of the trigeminal ganglionExp Neurol20041862 242 24715026260
  • Knyihár-CsillikEToldiJKrisztin-PévaBPrevention of electrical stimulation-induced increase of c-Fos immunoreaction in the caudal trigeminal nucleus by kynurenine combined with probenecidNeurosci Lett20074182 122 12617382471
  • Knyihár-CsillikEToldiJMihályAKynurenine in combination with probenecid mitigates the stimulation-induced increase of c-Fos immunoreactivity of the rat caudal trigeminal nucleus in an experimental migraine modelJ Neural Transm (Vienna)20071144 417 42116897600
  • SalvatiPUkmarGDhoLBrain concentrations of kynurenic acid after a systemic neuroprotective dose in the gerbil model of global ischemiaProg Neuropsychopharmacol Biol Psychiatry1999234 741 75210390731
  • GorelovaNAKrivánekJBuresJFunctional and metabolic correlates of long series of cortical spreading depression waves in ratsBrain Res19874041–2 379 3813032340
  • KudoCNozariAMoskowitzMAAyataCThe impact of anesthetics and hyperoxia on cortical spreading depressionExp Neurol20082121 201 20618501348
  • Batista-de-OliveiraMLopesAAMendes-da-SilvaRFGuedesRCAging-dependent brain electrophysiological effects in rats after distinct lactation conditions, and treadmill exercise: a spreading depression analysisExp Gerontol2012476 452 45722504277
  • BatesEANikaiTBrennanKCSumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in miceCephalalgia2010302 170 17819489890
  • GuptaSVillalónCMThe relevance of preclinical research models for the development of antimigraine drugs: focus on 5-HT(1B/1D) and CGRP receptorsPharmacol Ther20101281 170 19020655327
  • LinkASKurisAEdvinssonLTreatment of migraine attacks based on the interaction with the trigemino-cerebrovascular systemJ Headache Pain200891 5 1218217201
  • BowyerSMAuroraKSMoranJETepleyNWelchKMMagnetoencephalographic fields from patients with spontaneous and induced migraine auraAnn Neurol2001505 582 58711706963
  • HadjikhaniNDel RioMSWuOMechanisms of migraine aura revealed by functional MRI in human visual cortexProc Natl Acad Sci U S A2001988 4687 469211287655
  • AyataCJinHKudoCDalkaraTMoskowitzMASuppression of cortical spreading depression in migraine prophylaxisAnn Neurol2006594 652 66116450381
  • CostaCTozziARaineroICortical spreading depression as a target for anti-migraine agentsJ Headache Pain201314 6223879550
  • Eikermann-HaerterKLeeJHYalcinNMigraine prophylaxis, ischemic depolarizations, and stroke outcomes in miceStroke2015461 229 23625424478
  • Eikermann-HaerterKCanAAyataCPharmacological targeting of spreading depression in migraineExpert Rev Neurother2012123 297 30622364328
  • WangMObrenovitchTPUrenjakJEffects of the nitric oxide donor, DEA/NO on cortical spreading depressionNeuropharmacology2003447 949 95712726826
  • PetzoldGCHaackSvon Bohlen und HalbachONitric oxide modulates spreading depolarization threshold in the human and rodent cortexStroke2008394 1292 129918309156
  • UlmerHJde LimaVMHankeWEffects of nitric oxide on the retinal spreading depressionBrain Res19956911–2 239 2428590060
  • ReadSJSmithMIHunterAJUptonNParsonsAASB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized catCephalalgia2000202 92 9910961764
  • ReadSJSmithMIHunterAJParsonsAAEnhanced nitric oxide release during cortical spreading depression following infusion of glyceryl trinitrate in the anaesthetized catCephalalgia1997173 159 1659170338
  • LambertGAHoskinKLZagamiASCortico-NRM influences on trigeminal neuronal sensationCephalalgia2008286 640 65218454788
  • WangXFangYLiangJYanMHuRPanX5-HT7 receptors are involved in neurogenic dural vasodilatation in an experimental model of migraineJ Mol Neurosci2014542 164 17024584680
  • ReadSJParsonsAASumatriptan modifies cortical free radical release during cortical spreading depression: a novel antimigraine action for sumatriptan?Brain Res20008701–2 44 5310869500
  • Maranhão-FilhoPAMartins-FerreiraHVincentMBRibeiroLJNovisSASumatriptan blocks spreading depression in isolated chick retinaCephalalgia1997178 822 8259453269
  • IngvardsenBKLaursenHOlsenUBHansenAJPossible mechanism of c-Fos expression in trigeminal nucleus caudalis following cortical spreading depressionPain1997723 407 4159313281
  • BradleyDPSmithMINetsiriCDiffusion-weighted MRI used to detect in vivo modulation of cortical spreading depression: comparison of sumatriptan and tonabersatExp Neurol20011722 342 35311716558
  • OláhGHerédiJMenyhártAUnexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood-brain barrier permeabilityDrug Des Devel Ther2013167 981 987
  • Knyihar-CsillikEMihalyAKrisztin-PevaBThe kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-Fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acidNeurosci Res2008614 429 43218541319
  • VámosEPárdutzAVargaHL-Kynurenine combined with probenecid and the novel synthetic kynurenic acid derivative attenuate nitroglycerin-induced nNOS in the rat caudal trigeminal nucleusNeuropharmacology2009574 425 42919580819
  • VámosEFejesAKochJKynurenate derivative attenuates the nitroglycerin-induced CamKIIα and CGRP expression changesHeadache2010505 834 84319925620